ARC Definite Stent Thrombosis Rates for the SYNERGY BP Stent1*
1. SWEET Registry: Cook TCT 2015., Fribourg Experience: Arroyo CRT 2016. Belfast Experience: Noad TCT 2015., EVOLVE II: Kereiakes, et al. Circ Cardiovasc Interv. 2015;8:e002372. doi:10.1161/CIRCINTERVENTIONS.114.002372.,EVOLVE FHU: Meredith et al. J Am Coll Cardiol. 2012;59(15):1362., EVOLVE II QCA: Meredith ACC 2015., SCAAR Registry: James TCT 2016 BIO-RESORT presented by Clemens von Birgelen, MD, PhD, TCT 2016.
The Kang et al (2016) meta-analysis is the most comprehensive network meta-analysis comparing contemporary coronary stents and scaffolds to date.
Promus PREMIER PP Stent vs. Comparators
2. Kang, S.et al. J Am Coll Cardiol Intv. doi:10.1016/j.jcin.2016.03.038
* Caution should be taken in interpreting study results, as some stents had limited numbers of comparisons, and some of the studies had a potential risk of bias. All PtCr-EES stents, also includes PROMUS Element and PROMUS Element Plus. Def/prob ST was available in 110 studies with 111,088 patients.
The SYNERGY BP Stent has impacted the lives of patients around the world, including Susie and Vincent. Watch their powerful stories.
Susie's life was turned upside down with the need for PCI or the possibility of surgery. The SYNERGY BP Stent provided a treatment option that offers rapid vessel healing to give her the quality of life she deserves.
Vincent was living with blocked arteries since he was in his early 30s. The SYNERGY BP Stent, designed with the goal of optimal healing, provided his physician with an exciting new treatment option for this case.